Recent Updates
Recently added Catalysts
ACB Positive Sentiment Score: 70/100

Aurora Cannabis to Host Fourth Quarter and Fiscal Year 2025 Investor Conference Call and File Related Year End Information NASDAQ | TSX

Key Takeaway: Aurora Cannabis announced plans to host a conference call on June 18, 2025, to discuss its financial results for the fourth quarter and fiscal year 2025. The company aims to provide investors with insights into its performance, following a report of results before market opening on the same day. Miguel Martin and Simona King will lead the discussion. Aurora continues to operate across medical and consumer markets globally.

Market Sentiment Analysis

POSITIVE FACTORS

  • Aurora Cannabis is a leader in the global medical cannabis market.
  • The scheduled conference call highlights the company's commitment to transparency with investors.
  • The report on fourth quarter results could indicate positive developments in financial performance.

Full Press Release Details

Aurora Cannabis to Host Fourth Quarter and Fiscal
Year 2025 Investor Conference Call and File Related Year End Information
EDMONTON, AB, June 3, 2025 /CNW/ - Aurora Cannabis
Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company,
announced today that it has scheduled a conference call to discuss the results for its fourth quarter and fiscal year 2025 on Wednesday,
June 18, 2025 at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time. The Company will report its financial results for the fourth quarter
fiscal year 2025 before the opening of markets that same day.
Conference Call Details
DATE: Wednesday, June 18, 2025
TIME: 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time
WEBCAST: Click Here
Miguel Martin, Executive Chairman and Chief Executive
Officer, and Simona King, Chief Financial Officer, will host the conference call and question and answer period. This weblink has
also been posted to the Company's "Investor Info" link at https://www.auroramj.com/investors/ under "Events".
About Aurora Cannabis
Aurora is opening the world to cannabis, serving both
the medical and consumer markets across Canada, Europe, Australia and New Zealand. Headquartered in Edmonton, Alberta, Aurora is a pioneer
in global cannabis, dedicated to helping people improve their lives. The Company's adult- use brand portfolio includes Drift, San
Rafael '71, Daily Special, Tasty's, Being and Greybeard. Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical
Marijuana Co, as well as international brands, Pedanios, IndiMed and CraftPlant. Aurora also has a controlling interest in Bevo Farms
Ltd., North America's leading supplier of propagated agricultural plants. Driven by science and innovation, and with a focus on high-quality
cannabis products, Aurora's brands continue to break through as industry leaders in the medical, wellness and adult recreational markets
Aurora's common shares trade on the NASDAQ and TSX
under the symbol "ACB".
Forward Looking Statements
This news release includes statements containing certain
"forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). Forward-looking
statements are frequently characterized by words such as "plan", "continue", "expect", "project",
"intend", "believe", "anticipate", "estimate", "may", "will", "potential",
"proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur.
Forward-looking statements made in this news release include, but are not limited to, statements regarding the timing of the release of
the Company's financial statements for fourth quarter and fiscal year ended March 31, 2025 and scheduling of the conference
call to discuss results.
These forward-looking statements are only predictions.
Forward looking information or statements contained in this news release have been developed based on assumptions management considers
to be reasonable. Material factors or assumptions involved in developing forward-looking statements include, without limitation, publicly
available information from governmental sources as well as from market research and industry analysis and on assumptions based on
data and knowledge of this industry which the Company believes to be reasonable. Forward-looking statements are subject to a variety of
risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual
events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in
the forward-looking statements. These risks include, but are not limited to, the timing, magnitude and duration of potential new or increased
tariffs imposed on goods imported from Canada into the United States, the ability to retain key personnel, the ability to continue
investing in infrastructure to support growth, the ability to obtain financing on acceptable terms, the continued quality of our
products, customer experience and retention, the development of third party government and non-government consumer sales channels, management's
estimates of consumer demand in Canada and in jurisdictions where the Company exports, expectations of future results and expenses, the
risk of successful integration of acquired business and operations (with respect to the Transaction and more generally with respect to
future acquisitions), management's estimation that SG&A will grow only in proportion of revenue growth, the ability to expand and
maintain distribution capabilities, the impact of competition, the general impact of financial market conditions, the yield from cannabis
growing operations, product demand, changes in prices of required commodities, competition, and the possibility for changes in laws, rules,
and regulations in the industry, epidemics, pandemics or other public health crises and other risks, uncertainties and factors set out
under the heading "Risk Factors" in the Company's annual information from dated June 20, 2024 (the "AIF") and
filed with Canadian securities regulators available on the Company's issuer profile on SEDAR+ at www.sedarplus.com and filed with and
available on the SEC's website at www.sec.gov. The Company cautions that the list of risks, uncertainties and other factors described
in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties
and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such information.
The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements,
whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.
SOURCE Aurora Cannabis Inc.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/June2025/03/c5736.html
For further information: For Media: Michelle Lefler, VP, Communications
& PR, media@auroramj.com; For Investors: ICR, Inc., Investor Relations, aurora@icrinc.com
CO: Aurora Cannabis Inc.
CNW 16:15e 03-JUN-25

Frequently Asked Questions

When is the Aurora Cannabis investor conference call?

The conference call is on June 18, 2025, at 8:00 a.m. ET.

What will Aurora Cannabis discuss in the conference call?

They will discuss the financial results for Q4 and fiscal year 2025.

Who will host the investor conference call?

Miguel Martin and Simona King will host the call.

Where can I find the webcast for the conference call?

The webcast link is on Aurora's Investor Info page.

What is Aurora Cannabis known for?

Aurora is a leading global medical cannabis company based in Canada.

Last updated: Jun 3, 2025